4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000104
Chief Business Officer gave up 1,102 shares (to pay taxes)
- Chief Business Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Scott N Chief Business Officer | 2024-11-07 | Option exercise | +3,750 | 57,669 | D | ||
| Boyle Scott N Chief Business Officer | 2024-11-07 | Shares withheld for taxes | −1,102 | $6.04 | $6,656 | 56,567 | D |
| Derivatives | |||||||
| Boyle Scott N Chief Business Officer | 2024-11-07 | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | D | ||
Loading xslF345X05/wk-form4_1731446256.xml…